Medabon gains market authorization in Kyrgyzstan

May 16, 2018 | Medabon®

Medabon, a quality assured mifepristone-misprostol combipack has been registered in Kyrgyzstan. This has been the culmination of tireless efforts on the ground and is the first combipack to be registered in the country. Registration of Medabon is a critical and first major step towards ensuring that more women in the country will have access to a safe choice for the termination of pregnancy.